FrancophonIA/ELRC3.0 huggingface dataset:
English: TRM values ranged from 0% to 7.4% confirming the safety of the conditioning treatment including thiotepa for autologous HPCT in adult patients with solid tumours.
Danish: TRM-værdierne varierede fra 0 % til 7,4 %, hvilket bekræfter sikkerheden ved konditionering med thiotepa til autolog HPCT hos voksne med solide tumorer.
English: Blood alkaline phosphatase increased
Danish: Forhøjet gammaglutamyltransferase Forhøjet alkalisk fosfatase i blodet Forhøjet aspartataminotransferase
English: - inflammation and exfoliation of the skin (erythrodermic psoriasis) - delirium, nervousness, hallucination, agitation - gastrointestinal ulcer - inflammation of the muscular tissue of the heart (myocarditis) - abnormal heart condition (cardiomyopathy)
Danish: Ikke almindelige bivirkninger (kan forekomme hos 1 ud af 100 personer) - betændelse i huden og afskalning af huden (erytrodermisk psoriasis) - delirium, nervøsitet, hallucination, uro - mavesår - betændelse i hjertets muskelvæv (myocarditis) - abnorm hjertetilstand (kardiomyopati)
English: Regimen Related Mortality (RRM) and Transplant Related Mortality (TRM): RRM values ranging from 2.5% to 29% have been reported.
Danish: Behandlingsrelateret mortalitet (BRM) og transplantationsrelateret mortalitet (TRM): Der er rapporteret BRM-værdier fra 2,5 % til 29 %.
English: The recommended dose in lymphoma is 370 mg/m2/day (10 mg/kg/day) divided in two daily infusions before allogeneic HPCT, without exceeding the total maximum cumulative dose of 370 mg/m2 (10 mg/kg), during the time of the entire conditioning treatment.
Danish: Den anbefalede dosis ved lymfomer er 370 mg/m2/dag (10 mg/kg/dag) fordelt på to daglige infusioner, der indgives før allogen HPCT, uden at den totale maksimale kumulerede dosis på 370 mg/m (10 mg/kg) overskrides under hele konditioneringen.
English: TRM values ranged from 0% to 21% at 1 year, confirming the safety of the conditioning treatment including thiotepa for autologous HPCT in adult patients with haematological diseases.
Danish: TRM-værdierne varierede fra 0 % til 21 % efter ét år, hvilket bekræfter sikkerheden ved konditioneringen med thiotepa til autolog HPCT hos voksne med hæmatologiske sygdomme.
English: CENTRAL NERVOUS SYSTEM (CNS) LYMPHOMA The recommended dose is 185 mg/m2/day (5 mg/kg/day) as a single daily infusion, administered for 2 consecutive days before autologous HPCT, without exceeding the total maximum cumulative dose of 370 mg/m2 (10 mg/kg), during the time of the entire conditioning treatment.
Danish: CENTRALNERVESYSTEM (CNS)-LYMFOMER Den anbefalede dosis er 185 mg/m2/dag (5 mg/kg/dag) som en enkelt daglig infusion, der indgives i to på hinanden følgende dage før autolog HPCT, uden at den totale maksimale kumulerede dosis på 370 mg/m
English: Using a syringe fitted with a needle, aseptically withdraw 1.5 ml of sterile water for injection.
Danish: Ved hjælp af en sprøjte med kanyle udtrækkes 1,5 ml sterilt vand til injektion aseptisk.
English: Idiopathic pneumonia syndrome Pulmunary haemorrage Pulmonary oedema
Danish: Idiopatisk lungesygdom Næseblod
English: Regimen Related Mortality (RRM) and Transplant Related Mortality (TRM): RRM values ranging from 0% to 2% have been reported.
Danish: Behandlingsrelateret mortalitet (BRM) og transplantationsrelateret mortalitet (TRM): Der er rapporteret BRM-værdier fra 0 % til 2 %.
English: TEPADINA 100 mg powder for concentrate for solution for infusion Thiotepa
Danish: TEPADINA 100 mg pulver til koncentrat til infusionsvæske, opløsning Thiotepa
English: The recommended dose in lymphoma is 370 mg/m2/day (10 mg/kg/day) divided in two daily infusions before allogeneic HPCT, without exceeding the total maximum cumulative dose of 370 mg/m2
Danish: Den anbefalede dosis er 370 mg/m2/dag (10 mg/kg/dag) fordelt på to daglige infusioner, der indgives før allogen HPCT, uden at den totale maksimale kumulerede dosis på 370 mg/m
English: Using a syringe fitted with a needle, aseptically withdraw 10 ml of sterile water for injection.
Danish: Ved hjælp af en sprøjte med kanyle udtrækkes 10 ml sterilt vand til injektion aseptisk.
English: Tell your doctor if you are taking, have recently taken or might take any other medicines.
Danish: Brug af anden medicin sammen med TEPADINA Fortæl det altid til lægen, hvis du bruger anden medicin eller har gjort det for nylig.
English: The recommended dose ranges from 185 mg/m2/day (5 mg/kg/day) to 481 mg/m2/day (13 mg/kg/day) divided in one or two daily infusions, administered from 1 up to 2 consecutive days before allogeneic HPCT depending on the combination with other chemotherapeutic medicinal products, without exceeding the total maximum cumulative dose of 555 mg/m2 (15 mg/kg), during the time of the entire conditioning treatment.
Danish: Den anbefalede dosis varierer fra 185 mg/m2/dag (5 mg/kg/dag) til 481 mg/m2/dag (13 mg/kg/dag) fordelt på en eller to daglige infusioner, der indgives fra en til to på hinanden følgende dage før allogen HPCT afhængigt af kombinationen med andre kemoterapeutika, uden at den totale maksimale kumulerede dosis på 555 mg/m
English: TEPADINA 100 mg powder for concentrate for solution for infusion
Danish: TEPADINA 100 mg pulver til koncentrat til infusionsvæske, opløsning
English: TEPADINA 15 mg powder for concentrate for solution for infusion Thiotepa
Danish: TEPADINA 15 mg pulver til koncentrat til infusionsvæske, opløsning Thiotepa
English: TEPADINA 15 mg powder for concentrate for solution for infusion
Danish: TEPADINA 15 mg pulver til koncentrat til infusionsvæske, opløsning
English: Epistaxis Hypoxia
Danish: Hypopituitarisme Hypogonadisme Hypotyroidisme
English: Cognitive disorder Cerebral haemorrhage
Danish: Intrakraniel aneurisme Ekstrapyramidale symptomer Kognitiv forstyrrelse Hjerneblødning
English: Each TEPADINA vial must be reconstituted with 1.5 ml of sterile water for injection.
Danish: Hvert hætteglas med TEPADINA skal rekonstitueres med 1,5 ml sterilt vand til injektionsvæsker.
English: TRM values ranged from 0% to 18% confirming the safety of the conditioning treatments including thiotepa for autologous HPCT in paediatric patients with solid tumours.
Danish: TRM-værdierne varierede fra 0 % til 18 %, hvilket bekræfter sikkerheden ved konditioneringer med thiotepa til autolog HPCT hos børn med solide tumorer.
English: Immedica Pharma AB Puh/Tel: +46 (0)8 533 39 500
Danish: Suomi/Finland Immedica Pharma AB Puh/Tel: +46 (0)8 533 39 500
English: TRM values ranged from 0% to 30% confirming the safety of the conditioning treatment including thiotepa for allogeneic HPCT in paediatric patients with haematological diseases.
Danish: TRM-værdierne varierede fra 0 % til 30 %, hvilket bekræfter sikkerheden ved konditionering med thiotepa til allogen HPCT hos børn med hæmatologiske sygdomme.
English: The recommended dose in solid tumours ranges from 150 mg/m2/day (6 mg/kg/day) to 350 mg/m2/day (14 mg/kg/day) as a single daily infusion, administered from 2 up to 3 consecutive days before autologous HPCT depending on the combination with other chemotherapeutic medicinal products, without exceeding the total maximum cumulative dose of 1050 mg/m2 (42 mg/kg), during the time of the entire conditioning treatment.
Danish: Den anbefalede dosis ved solide tumorer varierer fra 150 mg/m2/dag (6 mg/kg/dag) til 350 mg/m2/dag (14 mg/kg/dag) som en enkelt daglig infusion, der indgives fra to op til tre på hinanden følgende dage før autolog HPCT afhængigt af kombinationen med andre kemoterapeutika, uden at den totale maksimale kumulerede dosis på 1050 mg/m
English: Hepatic impairment
Danish: Slimhindeinflammation Smerte
English: The recommended dose in haematological diseases ranges from 185 mg/m2/day (5 mg/kg/day) to 481 mg/m2/day (13 mg/kg/day) divided in one or two daily infusions, administered from 1 up to 3 consecutive days before allogeneic HPCT depending on the combination with other chemotherapeutic medicinal products, without exceeding the total maximum cumulative dose of 555 mg/m2 (15 mg/kg), during the time of the entire conditioning treatment.
Danish: LEUKÆMI Den anbefalede dosis varierer fra 185 mg/m2/dag (5 mg/kg/dag) til 481 mg/m2/dag (13 mg/kg/dag) fordelt på en eller to daglige infusioner, der indgives fra en til to på hinanden følgende dage før allogen HPCT afhængigt af kombinationen med andre kemoterapeutika, uden at den totale maksimale kumulerede dosis på 555 mg/m
English: Regimen Related Mortality (RRM) and Transplant Related Mortality (TRM): RRM values ranging from 0% to 2.5% have been reported.
Danish: Behandlingsrelateret mortalitet (BRM) og transplantationsrelateret mortalitet (TRM): Der er rapporteret BRM-værdier fra 0 % til 2,5 %.
English: Each TEPADINA vial must be reconstituted with 10 ml of sterile water for injection.
Danish: Hvert hætteglas med TEPADINA skal rekonstitueres med 10 ml sterilt vand til injektionsvæsker.
English: The recommended dose is 125 mg/m2/day (5 mg/kg/day) as a single daily infusion, administered for 2 consecutive days before allogeneic HPCT, without exceeding the total maximum cumulative dose of 250 mg/m2 (10 mg/kg), during the time of the entire conditioning treatment.
Danish: GENETISKE SYGDOMME Den anbefalede dosis er 125 mg/m2/dag (5 mg/kg/dag) som en enkelt daglig infusion, der indgives i to på hinanden følgende dage før allogen HPCT, uden at den totale maksimale kumulerede dosis på 250 mg/m
English: The recommended dose ranges from 125 mg/m2/day (3.38 mg/kg/day) to 300 mg/m2/day (8.10 mg/kg/day) as a single daily infusion, administered from 2 up to 4 consecutive days before autologous HPCT depending on the combination with other chemotherapeutic medicinal products, without exceeding the total maximum cumulative dose of 900 mg/m2 (24.32 mg/kg), during the time of the entire conditioning treatment.
Danish: Den anbefalede dosis varierer fra 125 mg/m2/dag (3,38 mg/kg/dag) til 300 mg/m2/dag (8,10 mg/kg/dag) som en enkelt daglig infusion, der indgives fra to til fire på hinanden følgende dage før autolog HPCT afhængigt af kombinationen med andre kemoterapeutika, uden at den totale maksimale kumulerede dosis på 900 mg/m
English: Enteritis Intestinal obstruction
Danish: Enteritis Tarmobstruktion
English: The recommended dose ranges from 120 mg/m2/day (3.24 mg/kg/day) to 250 mg/m2/day (6.76 mg/kg/day) as a single daily infusion, administered from 3 up to 5 consecutive days before autologous HPCT depending on the combination with other chemotherapeutic medicinal products, without exceeding the total maximum cumulative dose of 800 mg/m2 (21.62 mg/kg), during the time of the entire conditioning treatment.
Danish: Den anbefalede dosis varierer fra 120 mg/m2/dag (3,24 mg/kg/dag) til 250 mg/m2/dag (6,76 mg/kg/dag) som en enkelt daglig infusion, der indgives fra tre til fem på hinanden følgende dage før autolog HPCT afhængigt af kombinationen med andre kemoterapeutika, uden at den totale maksimale kumulerede dosis på 800 mg/m
English: The recommended dose is 250 mg/m2/day (10 mg/kg/day) divided in two daily infusions, administered before allogeneic HPCT, without exceeding the total maximum cumulative dose of 250 mg/m2 (10 mg/kg), during the time of the entire conditioning treatment.
Danish: Den anbefalede dosis er 250 mg/m2/dag (10 mg/kg/dag) fordelt på to daglige infusioner, der indgives før allogen HPCT, uden at den totale maksimale kumulerede dosis på 250 mg/m
English: The recommended dose ranges from 150 mg/m2/day (4.05 mg/kg/day) to 250 mg/m2/day (6.76 mg/kg/day) as a single daily infusion, administered for 3 consecutive days before autologous HPCT depending on the combination with other chemotherapeutic medicinal products, without exceeding the total maximum cumulative dose of 750 mg/m2 (20.27 mg/kg), during the time of the entire conditioning treatment.
Danish: Den anbefalede dosis varierer fra 150 mg/m2/dag (4,05 mg/kg/dag) til 250 mg/m2/dag (6,76 mg/kg/dag) som en enkelt daglig infusion, der indgives i tre på hinanden følgende dage før autolog HPCT afhængigt af kombinationen med andre kemoterapeutika, uden at den totale maksimale kumulerede dosis på 750 mg/m
English: Arrhythmia
Danish: Høreskade
English: The recommended dose is 125 mg/m2/day (5 mg/kg/day) as a single daily infusion, administered for 3 consecutive days before allogeneic HPCT, without exceeding the total maximum cumulative dose of 375 mg/m2 (15 mg/kg), during the time of the entire conditioning treatment.
Danish: REFRAKTÆR CYTOPENI Den anbefalede dosis er 125 mg/m2/dag (5 mg/kg/dag) som en enkelt daglig infusion, der indgives i tre på hinanden følgende dage før allogen HPCT, uden at den totale maksimale kumulerede dosis på 375 mg/m
English: Stomatitis Oesophagitis Vomiting Diarrhoea Dyspepsia Abdominal pain Enteritis Colitis
Danish: Stomatitis Øsofagitis Opkastning Diarré
English: Allogeneic HPCT
Danish: ALLOGEN HPCT
English: Leukoencephalopathy
Danish: Lungeødemer Hoste
English: The recommended dose ranges from 250 mg/m2/day (10 mg/kg/day) to 350 mg/m2/day (14 mg/kg/day) as a single daily infusion, administered for 3 consecutive days before autologous HPCT depending on the combination with other chemotherapeutic medicinal products, without exceeding the total maximum cumulative dose of 1050 mg/m2 (42 mg/kg), during the time of the entire conditioning treatment.
Danish: CNS-TUMORER Den anbefalede dosis varierer fra 250 mg/m2/dag (10 mg/kg/dag) til 350 mg/m2/dag (14 mg/kg/dag) som en enkelt daglig infusion, der indgives i tre på hinanden følgende dage før autolog HPCT afhængigt af kombinationen med andre kemoterapeutika, uden at den totale maksimale kumulerede dosis på 1050 mg/m
English: The recommended dose ranges from 125 mg/m2/day (3.38 mg/kg/day) to 250 mg/m2/day (6.76 mg/kg/day) divided in one or two daily infusions, administered from 3 up to 4 consecutive days before autologous HPCT depending on the combination with other chemotherapeutic medicinal products, without exceeding the total maximum cumulative dose of 750 mg/m2 (20.27 mg/kg), during the time of the entire conditioning treatment.
Danish: CNS-TUMORER Den anbefalede dosis varierer fra 125 mg/m2/dag (3,38 mg/kg/dag) til 250 mg/m2/dag (6,76 mg/kg/dag) fordelt på en eller to daglige infusioner, der indgives fra tre til fire på hinanden følgende dage før autolog HPCT afhængigt af kombinationen med andre kemoterapeutika, uden at den totale maksimale kumulerede dosis på 750 mg/m
English: Rash
Danish: Sepsis
English: The recommended dose is 250 mg/m2/day (6.76 mg/kg/day) as a single daily infusion, administered in 2 consecutive days before autologous HPCT, without exceeding the total maximum cumulative dose of 500 mg/m2 (13.51 mg/kg), during the time of the entire conditioning treatment.
Danish: ÆGGESTOKKRÆFT Den anbefalede dosis er 250 mg/m2/dag (6,76 mg/kg/dag) som en enkelt daglig infusion, der indgives i to på hinanden følgende dage før autolog HPCT, uden at den totale maksimale kumulerede dosis på 500 mg/m
English: Elderly
Danish: Arytmi
English: (8.10 mg/kg/day) as a single daily infusion, administered from 2 up to 4 consecutive days before autologous HPCT depending on the combination with other chemotherapeutic medicinal products, without exceeding the total maximum cumulative dose of 900 mg/m2 (24.32 mg/kg), during the time of the entire conditioning treatment.
Danish: 300 mg/m2/dag (8,10 mg/kg/dag) som en enkelt daglig infusion, der indgives fra to til fire på hinanden følgende dage før autolog HPCT afhængigt af kombinationen med andre kemoterapeutika, uden at den totale, maksimale kumulerede dosis på 900 mg/m
English: - If you get any side effects, talk to your doctor.
Danish: - Kontakt lægen, hvis en bivirkning bliver værre, eller du får bivirkninger, som ikke er nævnt her.
English: The recommended dose in haematological diseases ranges from 125 mg/m2/day (5 mg/kg/day) to 250 mg/m2/day (10 mg/kg/day) divided in one or two daily infusions, administered from 1 up to 3 consecutive days before allogeneic HPCT depending on the combination with other chemotherapeutic medicinal products, without exceeding the total maximum cumulative dose of 375 mg/m2 (15 mg/kg), during the time of the entire conditioning treatment.
Danish: 250 mg/m2/dag (10 mg/kg/dag) fordelt på en eller to daglige infusioner, der indgives fra en til tre på hinanden følgende dage før allogen HPCT afhængigt af kombinationen med andre kemoterapeutika, uden at den totale maksimale kumulerede dosis på 375 mg/m
English: Cataract
Danish: Katarakt
English: Bladder disorders Renal failure Cystitis haemorrhagic
Danish: Blæresygdomme Nyresvigt Hæmorragisk cystitis
English: Metabolism and nutrition disorders Anorexia Hyperglycaemia
Danish: Anoreksi Hypoglykæmi
English: Transaminases increased
Danish: Nedsat nyrefunktion
English: Haemorrhage Embolism
Danish: Mave-tarmkanalen
English: ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS
Danish: Tabel over bivirkninger
English: The European Commission issued a decision on this opinion on 11/11/2016.
Danish: Europa-Kommissionen traf en afgørelse om denne udtalelse 11.11.2016.
English: What is Clenil?
Danish: Hvad er Clenil?
English: Clenil is marketed in the following EU Member States: France, Germany, Greece, Ireland and Italy.
Danish: Clenil markedsføres i følgende EU-medlemsstater: Frankrig, Tyskland, Grækenland, Irland og Italien.
English: Clenil has been authorised in the EU via national procedures.
Danish: Clenil er godkendt i EU via nationale procedurer.
English: The lowest dose needed to control symptoms should be used.
Danish: Der bør anvendes den laveste dosis, der er nødvendig til kontrol af symptomerne.
English: The company that markets these medicines is Chiesi and associated companies.
Danish: Den virksomhed, der markedsfører disse lægemidler, er Chiesi og associerede selskaber.
English: Regular follow-up is recommended to review the treatment response.
Danish: Der anbefales regelmæssig opfølgning til vurdering af reaktionen på behandlingen.
English: Why was Clenil reviewed?
Danish: Hvorfor blev Clenil vurderet igen?
English: The duration of treatment should not exceed 3 months, unless a diagnosis of asthma is likely.
Danish: Varigheden af behandlingen bør ikke overstige 3 måneder, medmindre en astmadiagnose er sandsynlig.
English: On 15 September 2016, the European Medicines Agency completed a review of Clenil.
Danish: Den 15. september 2016 afsluttede Det Europæiske Lægemiddelagentur en gennemgang af Clenil.
English: Having harmonised the indication, the CHMP also harmonised recommendations on the doses.
Danish: Efter harmonisering af indikationen harmoniserede CHMP også anbefalingerne om doser.
English: It is also available under the trade names of Becloneb, Beclospin and Sanasthmax.
Danish: Det fås også under handelsnavnene Becloneb, Beclospin og Sanasthmax.
English: The starting dose of Clenil depends on the frequency and severity of symptoms and it can be adjusted until symptoms are under control.
Danish: Startdosis af Clenil afhænger af symptomernes hyppighed og sværhed og kan tilpasses, indtil symptomerne er under kontrol.
English: The maximum daily dose is 3,200 micrograms in adults and adolescents (up to 1,600 micrograms taken twice a day) and 1,600 micrograms in children below 12 years (up to 800 micrograms taken twice a day).
Danish: Den maksimale dagsdosis er 3 200 µg til voksne og unge (op til 1 600 µg to gange dagligt), og 1 600 µg til børn under 12 år (op til 800 µg to gange dagligt).
English: Clenil is a medicine used for the maintenance treatment of asthma in adults and children.
Danish: Clenil er et lægemiddel, der anvendes til vedligeholdelsesbehandling af astma hos voksne og børn.
English: The Committee also harmonised other sections of the SmPC including sections 4.6 (fertility, pregnancy and lactation), 4.8 (side effects), and 5.1 (pharmacodynamics).
Danish: CHMP harmoniserede desuden andre punkter i produktresuméet, herunder punkt 4.6 (Fertilitet, graviditet og amning), 4.8 (Bivirkninger) og 5.1 (Farmakodynamik).
English: On 19 June 2015, the Italian medicines regulatory agency referred the matter to the CHMP in order to harmonise the marketing authorisations for Clenil and associated names in the EU.
Danish: Den 19. juni 2015 indbragte den italienske lægemiddelstyrelse sagen for CHMP med henblik på harmonisering af markedsføringstilladelserne for Clenil og relaterede navne i EU.
English: If no treatment benefit is observed within 2-3 months or if a diagnosis of asthma is not likely, Clenil should be discontinued to avoid unnecessary long-term exposure to inhaled corticosteroids and associated risks in children.
Danish: Hvis der ikke iagttages bedring ved behandlingen efter 2-3 måneder, eller hvis en astmadiagnose ikke er sandsynlig, bør behandlingen med Clenil ophøre for at undgå unødig langtidsudsættelse for inhalerede kortikosteroider og de tilknyttede risici hos børn.
English: The Agency's Committee for Medicinal Products for Human Use (CHMP) concluded that there is a need to harmonise the prescribing information for Clenil in the European Union (EU).
Danish: Agenturets Udvalg for Lægemidler til Mennesker (CHMP) konkluderede, at der er behov for harmonisering af produktinformationen for Clenil i Den Europæiske Union (EU).
English: In children up to 5 years of age, the decision to start Clenil for the treatment of recurrent wheezing should be determined by the severity and frequency of the wheezing episodes.
Danish: Hos børn op til femårsalderen vil beslutningen om at påbegynde behandling af tilbagevendende pibende vejrtrækning med Clenil blive baseret på sværheden og hyppigheden af episoderne med pibende vejrtrækning.
English: However, the Committee considered that Clenil can be used to treat recurrent wheezing in children up to 5 years of age because this use is supported by adequate data.
Danish: Udvalget fandt imidlertid, at Clenil kan anvendes til behandling af tilbagevendende pibende vejrtrækning hos børn indtil femårsalderen, da denne anvendelse underbygges af tilstrækkelige data.
English: Questions and answers on Clenil and associated names (beclometasone dipropionate, 400 and 800 microgram nebuliser suspension) EMA/612121/2016 Rev.1
Danish: Spørgsmål og svar om Clenil og relaterede navne (beclometasondipropionat, suspension til nebulisator, 400 og 800 µg) EMA/612121/2016 Rev.1
English: It is also used to treat recurrent wheezing (whistling sound made while breathing, caused by narrowed airways or inflammation) in children up to 5 years of age.
Danish: Det anvendes desuden til behandling af tilbagevendende pibende vejrtrækning, der skyldes forsnævrede luftveje eller inflammation, hos børn op til femårsalderen.
English: Questions and answers on Clenil and associated names (beclometasone dipropionate, 400 and 800 microgram nebuliser suspension)
Danish: Spørgsmål og svar om Clenil og relaterede navne (beclometasondipropionat, suspension til nebulisator, 400 og 800 µg)
English: Clenil contains the active substance beclometasone dipropionate (which belongs to a group of antiinflammatory medicines commonly known as ‘corticosteroids').
Danish: Clenil indeholder det aktive stof beclometasondipropionat (som hører til binyrebarkhormonerne, der er en gruppe antiinflammatoriske lægemidler).
English: The CHMP agreed that Clenil can be used for the maintenance treatment of asthma in adults and children when the use of pressurised or dry powder inhalers is unsatisfactory or inappropriate.
Danish: I CHMP var der enighed om, at Clenil kan anvendes til vedligeholdelsesbehandling af astma hos voksne og børn, når inhalationsspray eller pulverinhalatorer er utilfredsstillende eller uhensigtsmæssige.
English: The CHMP also agreed that Clenil should no longer be used to treat allergic rhinitis (inflammation of the nasal passages caused by an allergy, for example hay fever or allergy to dust mites) because the available data do not support this use and other medicines available as nasal sprays may be better tolerated.
Danish: I CHMP var der desuden enighed om, at Clenil ikke længere bør anvendes til behandling af allergiforårsaget inflammation af næsegangene, f.eks. høfeber eller allergi mod støvmider (allergisk rhinitis), da de foreliggende data ikke underbygger denne anvendelse, og da andre lægemidler, der fås som næsespray, måske tåles bedre.